Looking Into bluebird bio's Return On Capital Employed
November 30, 2022 at 09:48 AM EST
According to Benzinga Pro data, during Q3, bluebird bio (NASDAQ:BLUE) posted sales of $71 thousand. Earnings were up 23.59%, but ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.